PFBT
SANA icon

Parkside Financial Bank & Trust’s Sana Biotechnology SANA Stock Holding History

Parkside Financial Bank & Trust’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$650 Hold
186
– – ﹤0.01% 2549
2026
Q1 		$536 Hold
186
– – ﹤0.01% 2557
2025
Q4 		$758 Hold
186
– – ﹤0.01% 2435
2025
Q3 		$661 Hold
186
– – ﹤0.01% 2433
2025
Q2 		$278 Buy
186
+41
+28% +$85 ﹤0.01% 2650
2025
Q1 		$244 Buy
+145
New +$405 ﹤0.01% 2655

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Parkside Financial Bank & Trust's SANA Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Sana Biotechnology (SANA) position steady in Q2 2026 at 186 shares worth $650. The position accounts for ﹤0.01% of the portfolio, ranked #2549.

Parkside Financial Bank & Trust first reported a position in SANA in Q1 2025 and has held it in 6 quarters since. The position peaked at $758 in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Parkside Financial Bank & Trust held 186 shares of Sana Biotechnology worth $650 as of Q2 2026.
  • Parkside Financial Bank & Trust left its Sana Biotechnology share count unchanged in Q2 2026.
  • Sana Biotechnology made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2549 holding.
  • Parkside Financial Bank & Trust first reported a position in Sana Biotechnology in Q1 2025 and has held it in 6 quarters since.
  • Parkside Financial Bank & Trust's Sana Biotechnology position peaked at $758 in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.